BioMimetic Therapeutics' Series B Round

BioMimetic Therapeutics raised a round of funding on May 23, 2003.

BioMimetic Pharmaceuticals (BMTI) is a biopharmaceutical company focused on the development, commercialization and ultimate marketing of protein therapeutics for tissue and organ regeneration. The Com…

Articles about BioMimetic Therapeutics' Series B Round: